Thyroid color flow Doppler sonography: An adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormone

Thyroid

Volumn 16, Issue 10, 2006, Pages 989-995

  Bogazzi, Fausto ^a   Manetti, Luca ^a   Tomisti, Luca ^a   Rossi, Giuseppe ^b   Cosci, Chiara ^a   Sardella, Chiara ^a   Bartalena, Luigi ^c   Gasperi, Maurizio ^a   Macchia, Enrico ^a   Vitti, Paolo ^a   Martino, Enio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPHORIN A; LIOTHYRONINE; SEX HORMONE BINDING GLOBULIN; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPOPHYSIS ADENOMA; LABORATORY TEST; LIOTHYRONINE BLOOD LEVEL; LIOTHYRONINE SUPPRESSION TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THYROID BLOOD FLOW; THYROID GLAND; THYROID HORMONE RESISTANCE; THYROXINE BLOOD LEVEL;

ADENOMA; ADULT; AGED; DRUG RESISTANCE; FEMALE; HUMANS; HYPERPITUITARISM; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; THYROID GLAND; THYROID HORMONES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33846430938     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.989     Document Type: Article

References (31)

1. Scanlon MF, Toft AD 2000 Regulation of thyrotropin secretion. In: Braverman LE, Utiger RD (eds) Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. Lippincott, Pennsylvania, pp 234-253.
2. Yen PM 2001 Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142.
3. Zhang J, Lazar MA 2000 The mechanism of action of thyroid hormones. Annual Rev Physiol 62:439-466.
4. Lazar MA 2003 Thyroid hormone action: a binding contract. J Clin Invest 112:497-499.
5. Shulman AI, Mangelsdorf DJ 2005 Retinoid x receptor heterodimers in the metabolic syndrome. N Engl J Med 353:604-615.
6. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD 1996 Thyrotropin-secreting pituitary tumors. Endocr Rev 17:618-638.
7. Beck-Peccoz P, Persani L 2002 Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 5:83-88.
8. Valdes Socin H, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A 2003 The changing spectrum of TSH-secreting pituitary adenomas: Diagnosis and management in 43 patients. Eur J Endocrinol 148:433-442.
9. Sakurai A, Takeda K, Ain K, Ceccarelli P, Nakai A, Seino S, Bell GI, Refetoff S, DeGroot LJ 1989 Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci (USA) 86:8977-8981.
10. Takeda K, Sakurai A, DeGroot LJ, Refetoff S 1992 Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-beta gene. J Clin Endocrinol Metab 74:49-55.
11. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399.
12. Beck-Peccoz P, Chatterjee VKK 1994 The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4:225-232.
13. Yen PM 2003 Molecular basis of resistance to thyroid hormone. Trends Endocrinol Metab 14:327-333.
14. Weiss RE, Refetoff S 2000 Resistance to thyroid hormone. Rev Endocr Metab Dis 1:97-108.
15. Bogazzi F, Bartalena L, Brogioni S, Burelli L, Manetti L, Tanda ML, Gasperi M, Martino E 1999 Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: Studies in vivo by color flow Doppler sonography. Eur J Endocrinol 140:452-456.
16. Bogazzi F, Bartalena L, Martino E 1999 Color flow Doppler sonography of the thyroid. In: Baskin JH (ed) Thyroid Ultrasound and Ultrasound-Guided FNA Biopsy. Kluwer Academic Publishers, Massachusetts, pp 215-238.
17. Castagnone D, Rivolta R, Rescalli S, Baldini MI, Tozzi R, Cantalamessa L 1996 Color doppler sonography in Graves' disease: Value in assessing activity of disease and predicting outcome. Am J Roentgen 166:203-207.
18. Vitti P, Rago T, Mazzeo S, Brogioni S, Lampis M, De Liperi A, Bartolozzi C, Pinchera A, Martino E 1995 Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. J Endocrinol Invest 18:587-861.
19. Rails PW, Mayekawa DS, Lee KP, Colletti PM, Radin DR, Boswell WD, Halls JM (1988) Color-flow Doppler sonography in Graves' disease: "thyroid inferno". Am J Roentgen 150:781-784.
20. Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, Bartolozzi C, Martino E 1997 Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 7:541-545.
21. Bogazzi F, Bartalena L, Vitti P, Rago T, Brogioni S, Martino E 1996 Color flow Doppler sonography in thyrotoxicosis factitia. J Endocrinol Invest 19:603-606.
22. Plouet J, Bayard F 1994 Regulations of vasculotropin/vascular endothelial growth factor bioavailability. Horm Res 42:14-19.
23. Ramsden JD 2000 Angiogenesis in the thyroid gland. J Endocrinol 166:475-480.
24. Macchia E, Agostini M, Sarkissian G, Giorgilli G, Canale D, Scartabelli G, Margotat A, Torresani J, Pinchera A 1998 Detection of a new de novo mutation at codon 251 of exon 8 of thyroid hormone receptor beta gene in an Italian kindred with resistance to thyroid hormone. J Endocrinol Invest 21:226-233.
25. Yen PM, Cheng SY 2003 Germline and somatic thyroid hormone receptor mutations in man. J Endocrinol Invest 26:780-787.
26. Vitti P, Rago T 2003 Thyroid ultrasound as a predictor of thyroid disease. J Endocrinol Invest 26:686-689.
27. Thrusfield MV 2002 Veterinarian Epidemiology. 2nd ed. BlackWell Sciences, pp 279-281.
28. Weiss RE, Hawashi Y, Nagaya T, Petty KJ, Murata Y, Tunka H, Seo H, Refetoff S 1996 Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptors alfa or beta genes may be due to a defective co-factors. J Clin Endocrinol Metab 81:4196-4203.
29. Barreda R, Kaude JV, Fagien M, Drane WE 1991 Hypervascularity of nontoxic goiter as shown by color-coded Doppler sonography. Am J Roentgen 156:199.
30. Persani L, Asteria C, Tonacchera M, Vitti P, Chatterjee VKK, Beck-Peccoz P 1994 Evidence for the secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. J Clin Endocrinol Metab 78:1034-1039.
31. Persani L, Borgato S, Romoli R, Asteria C, Pizzocaro A, Beck-Peccoz P 1998 Changes in the degree of sialylation of carbohydrate chains modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states. J Clin Endocrinol Metab 83:2486-2492.